"Minor" Infractions Will Not Trigger Warning Letter Under Final CPG
This article was originally published in The Gray Sheet
Executive Summary
FDA inspections that uncover "minor nonconformities" with a company's quality system regulations (QSRs) will not draw regulatory follow-up action under the agency's soon-to-be-published final compliance program guidance (CPG) for medical device audits.